Delivery Order SPE2DB22D2211-SPE2DB25FSBSW
- Not listed
- The Defense Logistics Agency awarded a $1,396.85 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. This firm fixed price delivery order, issued on July 24, 2025, with an ultimate completion date of August 14, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,352.44 for 100-unit vials of Xeomin, a botulinum toxin injection used primarily for treating muscle spasticity and other neurological conditions. This non-competitive, firm fixed-price delivery order was awarded on July 22, 2025, with an ultimate completion date of August 12, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency awarded a $1,396.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for medical and therapeutic applications. This non-competitive delivery order, issued on July 21, 2025, is scheduled for completion by August 11, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a small-value transaction within the company's broader federal pharmaceutical...
- The Defense Logistics Agency awarded a $13,968.50 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin on July 24, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as the prime contractor fulfilling this...
- The Defense Logistics Agency awarded a $11,174.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Xeomin 200 Unit Vials, with completion scheduled for August 8, 2025. This competitively awarded contract, issued without set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The U.S. Defense Department's Medical Supply Chain awarded a $44,466.24 delivery order to AmerisourceBergen Drug Corp for 100-unit vials of Xeomin, a botulinum toxin product used for therapeutic and cosmetic medical applications. Issued on July 23, 2025, with completion targeted for August 13, 2025, this firm fixed-price contract represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics...
- This delivery order, awarded July 25, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, covers the supply of Xeomin 100 Unit Vials with a ceiling value of $1,396.85 and an ultimate completion date of August 15, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency Troop Support Medical awarded a $1,310.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 units of Xeomin, a botulinum toxin type A. Place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on September 15, 2023 and ending on October 13, 2023. No major subcontractors or set aside designations were identified. This delivery order was issued...
- This delivery order for $7,863.75, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corporation, is for the delivery of 200 units of Xeomin, a botulinum toxin used for medical purposes. The contract has a firm fixed price and period of performance through November 6, 2023. To be delivered to a location in Conshohocken, Pennsylvania, this order was issued under an existing indefinite-delivery/indefinite-quantity contract vehicle but did not have a set-aside designation. The...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a $13,106 firm fixed price delivery order contract to provide 200 units of Xeomin, a botulinum toxin used for medical treatments. As the prime contractor, Amerisourcebergen will deliver the products to a location in Conshohocken, Pennsylvania by August 4, 2023 after the July 14 period of performance start date. No subcontractors or set aside designations were indicated. The Defense Logistics Agency routinely contracts for...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSBSWDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,984.25 for 100-unit vials of Xeomin on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. Xeomin is a botulinum toxin product used for therapeutic and cosmetic applications, and this delivery order represents a discrete procurement action within AmerisourceBergen's broader federal contract portfolio. This delivery order is a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen's status as a competitively awarded, non-set-aside contractor reflects its established capability to meet rigorous federal procurement standards and serve critical healthcare requirements across the Defense Health Agency, U.S. Coast Guard, and other government medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 7/28/25 |